Crea il mio profilo
Accesso pubblico
Visualizza tutto73 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Irene GhobrialDana-Farber Cancer InstituteEmail verificata su dfci.harvard.edu
- Aldo RoccaroASST Spedali Civili di Brescia, Brescia, ItalyEmail verificata su asst-spedalicivili.it
- Barbara MuzSenior Scientist, WUGENEmail verificata su wugen.com
- Pilar de la PuenteSanford Research. Cancer Biology and ImmunotherapiesEmail verificata su sanfordhealth.org
- Charles LinMassachusetts General Hospital, Harvard Medical SchoolEmail verificata su hms.harvard.edu
- Michaela ReaganMaine Health Institute for ResearchEmail verificata su mainehealth.org
- Noha Nabil SalamaCairo University Faculty of Pharmacy and St. Louis College of PharmacyEmail verificata su pharma.cu.edu.eg
- Samuel AchilefuUniversity of Texas Southwestern Medical Center, DallasEmail verificata su UTSouthwestern.edu
- Kinan AlhallakNortheastern UniversityEmail verificata su northeastern.edu
- Abraham (Avri) RubinsteinProfessor of Phramceutical Sciences, The Hebrew University of JerusalemEmail verificata su ekmd.huji.ac.il
- James D GriffinDana-Farber Cancer InstituteEmail verificata su dfci.harvard.edu
- Michele Moschetta, MD PhDExecutive Director, Early Clinical Development Oncology, AstraZenecaEmail verificata su astrazeneca.com
Segui
Abdel Kareem Azab
Associate Professor, Biomedical Engineering, University of Texas Southwestern Medical Center
Email verificata su utsouthwestern.edu - Home page